Internal Healthcare Group Launches as a Comprehensive Referral Platform for Senior Care Services Across the U.S. and Australia
08 nov. 2024 12h29 HE | Internal Healthcare
TAMPA, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Internal Healthcare Group, a newly founded senior referral service, is excited to announce its virtual launch, introducing a unique approach to...
Bridging Health Equi
Bridging Health Equity Gaps: Creyos Launches an Even More Accessible Patient Experience
05 nov. 2024 08h00 HE | Creyos
Toronto, Canada, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Creyos, a leader in cognitive and behavioral health assessment, has announced significant enhancements to its online platform to improve...
22157.jpg
Psychiatry Collaboration and Licensing Deals Agreements Report and Directory 2024: Upfront, Milestone, Royalties - Company A-Z, Therapy Focus and Technology Type
30 sept. 2024 05h20 HE | Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Psychiatry Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Psychiatry Collaboration and...
tiziana-logo.png
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
19 sept. 2024 07h00 HE | Tiziana Life Sciences Ltd.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Veera Anantha
VitalCaring’s AI-driven Cognitive Care Pilot Shows Promising Results
12 sept. 2024 07h26 HE | Constant Therapy Health; VitalCaring
VitalCaring’s AI-driven cognitive care pilot shows statistically significant cognitive improvements. Provider to extend initiative across its network.
Author Sonya Jury Shares Life Lessons in Her New Book Mom Forgot My Birthday: A Daughter’s Journey Through Alzheimer’s
26 août 2024 07h00 HE | Sonya Jury, Author
Sonya Jury shares her lessons as a caregiver in her book, "Mom Forgot My Birthday: A Daughter’s Journey Through Alzheimer’s."
finacialnews-logo-final-01 (2).png
Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
06 août 2024 09h00 HE | FN Media Group LLC
PALM BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to a report from Mordor Intelligence, the Alzheimer's Disease Diagnostics And Therapeutics Market size...
finacialnews-logo-final-01 (2).png
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033   
06 août 2024 08h30 HE | FN Media Group LLC
PALM BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The growth of the Alzheimer's Disease Therapeutics Market is directly influenced by the increasing prevalence of...
ZyversaREV_cmyk.jpg
ZyVersa Therapeutics Announces Published Data Demonstrating That Plasma Levels of Inflammasome ASC Show Promise as Biomarker of Early Cognitive Changes in Older Adults
29 juil. 2024 07h45 HE | ZyVersa Therapeutics
Plasma levels of inflammasome ASC show promise as a biomarker of early cognitive decline in older adults.
NKPH logo Globe Newswire.png
Nika Pharmaceuticals, Inc. (NIKA) Presents Its Business Strategy
03 juin 2024 10h35 HE | Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (NIKA) introduces its business strategy that should generate a net profit of more than 1 billion USD by the end of 2025.